"Providing no-cost research infrastructure to physicians. Increasing access to clinical trials. Helping patients access new medical treatments."

During the past decade, Hightower Clinical conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 1 clinical trials were completed, i.e. on average, 5% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 1 clinical trials were completed. i.e. 5.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hightower Clinical" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hightower Clinical" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Massachusetts General Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hightower Clinical" are "Crohn Disease" (3 trials), "Migraine" (3 trials), "Bradycardia" (2 trials), "Cardiac Rhythm Disorder" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Hightower Clinical" in a lesser frequency.

Most popular intervention types in "Hightower Clinical" are "Drug" (16 trials), "Other" (6 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ozanimod" (3 trials), "Giredestrant" (2 trials), "LHRH Agonist" (2 trials) and "Aveir DR Leadless Pacemaker System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hightower Clinical" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Hightower Clinical". undefined are not yet recruiting, 15 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hightower Clinical, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hightower Clinical, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".